Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Income (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Net Income data on record, last reported at -$5.9 million in Q3 2025.

  • For Q3 2025, Net Income rose 77.88% year-over-year to -$5.9 million; the TTM value through Sep 2025 reached -$87.1 million, up 26.52%, while the annual FY2024 figure was -$120.8 million, 21.61% up from the prior year.
  • Net Income reached -$5.9 million in Q3 2025 per FBIO's latest filing, up from -$35.9 million in the prior quarter.
  • Across five years, Net Income topped out at -$5.9 million in Q3 2025 and bottomed at -$62.3 million in Q4 2021.
  • Average Net Income over 5 years is -$37.6 million, with a median of -$35.9 million recorded in 2025.
  • Peak YoY movement for Net Income: tumbled 159.57% in 2021, then soared 78.69% in 2023.
  • A 5-year view of Net Income shows it stood at -$62.3 million in 2021, then rose by 7.92% to -$57.4 million in 2022, then surged by 49.5% to -$29.0 million in 2023, then rose by 18.79% to -$23.5 million in 2024, then soared by 74.91% to -$5.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$5.9 million in Q3 2025, -$35.9 million in Q2 2025, and -$21.8 million in Q1 2025.